Micreos Group
Micreos Group is a Dutch biotech company, founded in 2005, that develops proprietary endolysin and bacteriophage-based antimicrobial solutions for skin health (Gladskin) and food safety (PhageGuard) applications.
- Company typePrivate
- Founded2005
- HeadquartersBilthoven, Netherlands
- Headcount51–100
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Micreos Group does
Micreos Group is a privately held Dutch biotechnology company headquartered in Bilthoven, Netherlands, founded in 2005. The company develops endolysin and bacteriophage-based solutions targeting two distinct application verticals: skin health, commercialized through its Gladskin consumer brand, and food safety, commercialized through its PhageGuard brand. The underlying technology leverages naturally occurring phage-derived enzymes (endolysins) and intact bacteriophages as targeted antimicrobial agents, offering an alternative to conventional antibiotics and chemical preservatives.
The company operates with 51-100 employees and maintains a private, for-profit corporate structure. No further firmographic detail — including funding history, ownership, customer base, pricing, geographic footprint, management roster, or revenue — is available in the supplied data, as the company's website scraping was blocked by a verification/loading page. This represents a significant data gap for deeper due diligence.
Micreos' business model appears to combine a direct-to-consumer motion (Gladskin skincare products targeting consumers with skin conditions such as eczema and acne) with a B2B ingredient or licensing motion (PhageGuard applications for food producers seeking biopreservative alternatives). However, without disclosed revenue mechanics, customer counts, or pricing structures, the relative weighting of these channels and overall revenue scale cannot be assessed from the available information.
Micreos Group firmographics
Firmographics- Name
- Micreos Group
- Website
- https://micreos-group.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Micreos Group is a Dutch biotech company, founded in 2005, that develops proprietary endolysin and bacteriophage-based antimicrobial solutions for skin health (Gladskin) and food safety (PhageGuard) applications.
- Ownership category
- akta.pro rank
Micreos Group industry classification
Industry- Product category
- Antimicrobial Biotechnology
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Food And Kindred Products (2000), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Natural Antimicrobials & Clean-Label Preservatives (Plant Extracts, Essential Oils, Fermented Extracts) (AFAJAFAF)
- akta.pro secondary industries
- Protective Cultures & Biopreservation (Anti-Listeria, Anti-Mold, Shelf-Life Cultures) (AFAJAJAF), Preservatives & Antimicrobials (Sorbates, Benzoates, Natamycin, Cultured Dextrose) (CRADAOAF), Hand Sanitizers & Antibacterial Personal Care (CRADANAI), Antibacterial & Medicated Cleansers (e.g., Acne, Antifungal, Antiseptic) (CRABAEAH)
Keywords
Where Micreos Group is headquartered
LocationHeadquarters
- HQ city
- Bilthoven
- HQ country
- Netherlands
- HQ region
- Europe
Markets served
Micreos Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Micreos Group product offering
Product offeringCore offering
Micreos Group develops and commercializes endolysin- and bacteriophage-based antibacterial solutions. Its consumer-facing Gladskin brand offers microbiome-friendly skincare products for conditions such as eczema, acne, rosacea and sensitive skin, while its PhageGuard brand provides food-safety bioprotection products used by meat, poultry and other food producers to control specific pathogenic bacteria such as Salmonella and Listeria.
Differentiator
Problem solved
Functional benefit
Products and services
- Gladskin
Companies that use Micreos Group
Customer profileIdeal customer profiles2 records
Micreos Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Micreos Group partnerships and signals
Strategic signalExpansion highlights1 record
Micreos Group competitors and assessment
Company assessmentEmerging players
- SkinBioTherapeutics: SkinBioTherapeutics develops microbiome-based skincare ingredients and consumer products, paralleling Micreos's Gladskin line in applying biological science to skin health.
- Eligo Bioscience: Eligo Bioscience develops phage-based and microbiome-engineering platforms for therapeutic and consumer applications, sharing Micreos's core bacteriophage technology foundation.
- Locus Fermentation Solutions: Locus FS produces biological fermentation-derived ingredients, including clean-label antimicrobials and shelf-life solutions that compete with Micreos's PhageGuard in natural food preservation.
- AOBiome: AOBiome develops live bacterial and microbiome-based therapeutics for skin conditions, sharing Gladskin's biological approach to skin health with a more clinical/therapeutic orientation.
Broad incumbents
- BioGaia: BioGaia is an established probiotic health-products company whose probiotic formulations for skin and consumer health overlap thematically with Gladskin's microbiome-based skin positioning.
- International Flavors & Fragrances (IFF): IFF is a global food ingredients and biosciences major whose Health & Biosciences division includes antimicrobials, cultures, and food protection solutions that overlap with PhageGuard's food safety applications.
- Novonesis (formerly Novozymes / Chr. Hansen): Novonesis is a global bioscience leader offering food cultures, enzymes, and bioprotection solutions; its bioprotective cultures overlap with Micreos's clean-label food preservation positioning at much larger scale.
- DuPont Nutrition & Biosciences (IFF Danisco): DuPont's cultures and preservatives portfolio (now part of IFF) competes directly with PhageGuard in supplying antimicrobial and shelf-life extension solutions to food manufacturers.
Direct peers
- Intralytix: Intralytix develops and commercializes phage-based products for food safety, directly overlapping Micreos's PhageGuard portfolio and serving similar food-processing customers with bacteriophage antimicrobial solutions.
- Phagelux: Phagelux applies phage technology to food safety and agricultural applications, competing head-to-head with PhageGuard in biological antimicrobials for the food industry.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Micreos Group social profiles
Digital presenceMicreos Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Micreos Group leadership team
Management profileNumber of profiles
Micreos Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Micreos Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Micreos Group
What does Micreos Group do?
Micreos Group develops and commercializes endolysin- and bacteriophage-based antibacterial solutions. Its consumer-facing Gladskin brand offers microbiome-friendly skincare products for conditions such as eczema, acne, rosacea and sensitive skin, while its PhageGuard brand provides food-safety bioprotection products used by meat, poultry and other food producers to control specific pathogenic bacteria such as Salmonella and Listeria.
Is Micreos Group a public or private company?
Micreos Group is a private company. It is classified as venture growth investor backed and is currently operating.
When was Micreos Group founded?
Micreos Group was founded in 2005. It employs 51 to 100 people.
Where is Micreos Group based?
Micreos Group is headquartered in Bilthoven, Netherlands, in the Europe region.
Who are Micreos Group's main competitors?
Emerging players on record are SkinBioTherapeutics, Eligo Bioscience, Locus Fermentation Solutions and AOBiome. Broad incumbents are BioGaia, International Flavors & Fragrances (IFF), Novonesis (formerly Novozymes / Chr. Hansen) and DuPont Nutrition & Biosciences (IFF Danisco). Direct peers are Intralytix and Phagelux.
Does Micreos Group have an API?
No public API is recorded for Micreos Group.
What industry is Micreos Group in?
Micreos Group's product category is Antimicrobial Biotechnology. Its primary akta.pro industry code is AFAJAFAF, Natural Antimicrobials & Clean-Label Preservatives (Plant Extracts, Essential Oils, Fermented Extracts), with a secondary code of AFAJAJAF, Protective Cultures & Biopreservation (Anti-Listeria, Anti-Mold, Shelf-Life Cultures). Its NAICS code is 325412 and its SIC code is 2000.